Dismissal of Federal Circuit Appeal. Within three days of execution of this Agreement, Medytox shall pursue dismissal of the Federal Circuit Appeal as moot and agrees that as a result of the dismissal that the ITC’s final determination in 337-TA-1145 will be vacated.
Appears in 4 contracts
Samples: Settlement and License Agreement (AEON Biopharma, Inc.), Settlement and License Agreement (AEON Biopharma, Inc.), Settlement and License Agreement (AEON Biopharma, Inc.)
